Novel strategy can potentially control MAPK4-promoted growth in triple negative breas
In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies.
Threaded Mode